On November 16, the Office of Inspector General for the U.S. Department of Health and Human Services (OIG) published Advisory Opinion 21-16, approving an arrangement under which a pharmaceutical ...
Government revises new arrangement after considering public opinion and stakeholder feedback, with charges kicking in from fifth week after death.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback